Please Wait
Applying Filters...
menu
    • menu
    Fermion-PSE
    News
    Abilita and Orion Announce Research Collab to Next-Gen Antibody

    19 Dec 2024

    // PRESS RELEASE

    Orion Board Member Penalized for Delayed Transaction Notification

    12 Dec 2024

    // GLOBENEWSWIRE

    Orion Corporation Enters Collaboration with Evariste on Inhibitors

    10 Dec 2024

    // BUSINESSWIRE

    Data Compilation
    #PharmaFlow

    Fermion

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
    Menu

    Orion Corporation

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Abilita and Orion Announce Research Collab to Next-Gen Antibody
    Abilita and Orion Announce Research Collab to Next-Gen Antibody

    19 Dec 2024

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2024/orion-and-abilita-therapeutics-announce-research-collaboration-and-option-to-license-agreement-to-develop-innovative-antibody-therapeutics/

    PRESS RELEASE
    19 Dec 2024
    Share Share
    Orion Board Member Penalized for Delayed Transaction Notification
    Orion Board Member Penalized for Delayed Transaction Notification

    12 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/12/2996458/0/en/Penalty-payment-to-a-member-of-Orion-s-Board-of-Directors-for-delay-in-notifying-managers-transaction.html

    GLOBENEWSWIRE
    12 Dec 2024
    Share Share
    Orion Corporation Enters Collaboration with Evariste on Inhibitors
    Orion Corporation Enters Collaboration with Evariste on Inhibitors

    10 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241210955238/en

    BUSINESSWIRE
    10 Dec 2024
    Share Share
    142,701 Orion Corporation A shares converted into B shares
    142,701 Orion Corporation A shares converted into B shares

    27 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/27/2987966/0/en/142-701-Orion-Corporation-A-shares-converted-into-B-shares.html

    GLOBENEWSWIRE
    27 Nov 2024
    Share Share
    Orion Research Foundation grants EUR 1,109,000 for research in 2025
    Orion Research Foundation grants EUR 1,109,000 for research in 2025

    22 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/11/22/2985732/0/en/Orion-Research-Foundation-grants-EUR-1-109-000-for-research-in-2025.html

    GLOBENEWSWIRE
    22 Nov 2024
    Share Share
    Orion and Alligator Bio amend agreement 2 bispecific antibodies
    Orion and Alligator Bio amend agreement 2 bispecific antibodies

    20 Nov 2024

    // PRESS RELEASE

    https://www.orion.fi/en/newsroom/all-news/releases/press-releases/2024/orion-and-alligator-bioscience-amend-their-agreement-concerning-two-bispecific-antibodies/

    PRESS RELEASE
    20 Nov 2024
    Share Share